Study of cancer related outcomes for patients with advanced breast cancer undergoing breast preserving surgery after receiving chemotherapy.
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2018/12/016544
- Lead Sponsor
- Department of Surgical Disciplines
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All female patients registered under Surgery Unit III breast cancer clinic with:
1. Locally advanced breast cancer and primary tumor size greater than or equal to 5cm suitable for undergoing breast
conservation surgery post neoadjuvant chemotherapy.
2. Patient giving consent.
3. Minimum follow up of 6 months.
Exclusion Criteria
Breast cancer patients:
1. Having Chest wall fixation (T4a)
2. Having satellite nodules
3. Having inflammatory Carcinoma (T4d)
4. With Stages not included in the inclusion criteria.
5. Who are Pregnant, Lactating
6. Having contraindication to Radiotherapy.
7. With multicentric disease.
8. With diffuse microcalcifications on mammography.
9. Not giving consent.
10. With incomplete records.
11. Lost to follow up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the ipsilateral breast tumor recurrence (IBTR) in patients with Locally advanced breast cancer undergoing Breast conservation surgery post neoadjuvant chemotherapy.Timepoint: 31st March 2020
- Secondary Outcome Measures
Name Time Method 1. To ascertain the disease free survival (DFS) and overall survival (OS) in these patients. <br/ ><br>2. To study the factors associated with increased risk of ipsilateral breast tumor recurrence <br/ ><br>Timepoint: 31st March 2020